FACT in cell differentiation and carcinogenesis

Oncotarget

Volumn 2, Issue 11, 2011, Pages 830-832

  Hsieh, Fu Kai ^a   Kulaeva, Olga I ^a,b   Orlovsky, Igor V ^b   Studitsky, Vasily M ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; SSRP1 PROTEIN, HUMAN; TRANSCRIPTION ELONGATION FACTOR;

ANIMAL; CELL DIFFERENTIATION; CELL TRANSFORMATION; EDITORIAL; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; HIGH MOBILITY GROUP PROTEINS; HUMANS; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 84858815837     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.356     Document Type: Editorial

References (16)

1. Wittmeyer J, Formosa T. The Saccharomyces cerevisiae DNA polymerase alpha catalytic subunit interacts with Cdc68/Spt16 and with Pob3, a protein similar to an HMG1-like protein. Mol Cell Biol 1997; 17: 4178-4190.
2. Orphanides G, LeRoy G, Chang CH, Luse DS, Reinberg D. FACT, a factor that facilitates transcript elongation through nucleosomes. Cell 1998; 92: 105-116.
3. Belotserkovskaya R, Oh S, Bondarenko VA, Orphanides G, Studitsky VM, Reinberg D. FACT facilitates transcriptiondependent nucleosome alteration. Science 2003; 301: 1090-1093.
4. Orphanides G, Wu WH, Lane WS, Hampsey M, Reinberg D. The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. Nature 1999; 400: 284-288.
5. Saunders A, Werner J, Andrulis ED, Nakayama T, Hirose S, Reinberg D et al. Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo. Science 2003; 301: 1094-1096.
6. Mason PB, Struhl K. The FACT complex travels with elongating RNA polymerase II and is important for the fidelity of transcriptional initiation in vivo. Mol Cell Biol 2003; 23: 8323-8333.
7. Formosa T, Ruone S, Adams MD, Olsen AE, Eriksson P, Yu Y et al. Defects in SPT16 or POB3 (yFACT) in Saccharomyces cerevisiae cause dependence on the Hir/Hpc pathway: polymerase passage may degrade chromatin structure. Genetics 2002; 162: 1557-1571.
8. Cheung V, Chua G, Batada NN, Landry CR, Michnick SW, Hughes TR et al. Chromatin- and transcription-related factors repress transcription from within coding regions throughout the Saccharomyces cerevisiae genome. PLoS Biol 2008; 6: e277.
9. Kaplan CD, Laprade L, Winston F. Transcription elongation factors repress transcription initiation from cryptic sites. Science 2003; 301: 1096-1099.
10. McCullough L, Rawlins R, Olsen A, Xin H, Stillman DJ, Formosa T. Insight Into the Mechanism of Nucleosome Reorganization From Histone Mutants That Suppress Defects in the FACT Histone Chaperone. Genetics 2011; 188: 835-846.
11. Xin H, Takahata S, Blanksma M, McCullough L, Stillman DJ, Formosa T. yFACT induces global accessibility of nucleosomal DNA without H2A-H2B displacement. Mol Cell 2009; 35: 365-376.
12. Winkler DD, Muthurajan UM, Hieb AR, Luger K. The histone chaperone FACT coordinates nucleosome interaction through multiple synergistic binding events. J Biol Chem 2011.
13. Kulaeva OI, Gaykalova DA, Pestov NA, Golovastov VV, Vassylyev DG, Artsimovitch I et al. Mechanism of chromatin remodeling and recovery during passage of RNA polymerase II. Nat Struct Mol Biol 2009; 16: 1272-1278.
14. Garcia H, Fleyshman D, Kolesnikova K, Safina A, Commane M, Paszkiewicz G et al. Expression of FACT in mammalian tissues suggests its role in maintaining of undifferentiated state of cells. Oncotarget 2011.
15. Gasparian AV, Burkhart CA, Purmal AA, Brodsky L, Pal M, Saranadasa M et al. Curaxins: anticancer compounds that simultaneously suppress NF-kappaB and activate p53 by targeting FACT. Sci Transl Med 2011; 3: 95ra74.
16. Xiong L, Darwanto A, Sharma S, Herring J, Hu S, Filippova M et al. Mass spectrometric studies on epigenetic interaction networks in cell differentiation. J Biol Chem 2011; 286: 13657-13668.